CollabraTech Unveils Innovative Liquid Chemical Delivery System: Unlocking New Possibilities

The semiconductor industry is known for its intricate logistics and the challenges faced by companies in meeting the demands of a rapidly evolving technological landscape. In light of these challenges, CollabraTech Solutions, a local Arizona full-service capital equipment company, has developed a groundbreaking liquid chemical delivery system. This solution aims to transform the chemical delivery segment of the industry by addressing key pain points and offering unprecedented efficiency, reliability and flexibility.

With lead times traditionally quoted at 50 weeks for similar products, CollabraTech’s Liquid Chemical Delivery System disrupts the norm with an estimated lead time of just 20 weeks. This reduction in lead time is unprecedented and, in fact, sets a new industry standard. How do we achieve this? Our robust design configurator and supply chain strategies enable our customers to receive necessary systems quickly and efficiently, surpassing the limitations of traditional methods.

CollabraTech recognizes the value of flexibility in rapid component sourcing and production optimization. By establishing strong partnerships with a diverse range of reliable suppliers, the company enables customers to eliminate logistical obstacles. This flexibility empowers companies to optimize their production lines, minimize downtime and accelerate time-to-market.

There are other advantages of CollabraTech’s Liquid Chemical Delivery System. It offers optimized output capabilities, resulting in an impressive 33% boost in production output. This increase in efficiency translates to higher yields and lower costs per unit, providing significant cost savings for semiconductor manufacturers. And maximizing output empowers our customers to meet the industry’s growing demands while maintaining a competitive edge.

What sets CollabraTech apart from our competitors is our unwavering focus on delivering high-quality components quickly and cost-effectively, without compromising safety considerations. Major design benefits that drive the performance improvements of the new Liquid Delivery System include:

• Adding the Siemens S7 family of PLC-based control systems allows for lead-time reduction while offering comparable performance, compatibility and ease of integration with existing control systems.

• Six outlets that allow customers to supply more chambers per delivery system, reducing the initial capital outlay and ongoing maintenance costs.

• Flexible configurations that deliver chemistries for production and development applications for a variety of deposition and etch processes.

• Consistent delivery pressures across canisters that eliminate pressure fluctuations inherent in day tank systems, yielding improved vaporizer performance.

• Auto cross-over and canister refill from the optional Bulk system, enabling the continuous and uninterrupted flow of liquid precursor to the process tools.

• Increasing canister capacity of up to 38 liters, providing extended operational autonomy at the lowest cost per outlet in the industry.

CollabraTech’s Liquid Chemical Delivery System allows companies to accelerate their product design cycles, offering increased reliability and agility in this highly competitive market. CollabraTech understands the critical role collaboration and innovation play in overcoming industry obstacles. Strategic combination of reliable suppliers, reduced lead times and increased output capabilities means the impact of the Liquid Chemical Delivery System on the semiconductor landscape will be transformative, revolutionizing efficiency and reliability in the industry. CollabraTech Solutions remains committed to pushing the boundaries of technology and meeting the market’s evolving needs.

—Steve Lemons, president of CollabraTech Solutions (collabratech.com)

With lead times traditionally quoted at 50 weeks for similar products, CollabraTech’s Liquid Chemical Delivery System disrupts the norm with an estimated lead time of just 20 weeks.

Mental Health Services for Childhood Cancer Families

Chandler-based Children’s Cancer Network recently presented a check for $103,000 to Phoenix Children’s Foundation, the philanthropic arm of Phoenix Children’s, as the two Valley nonprofits collaborate to help families cope with the unimaginable diagnosis of childhood cancer. The funds will pay the salaries of two part-time mental health clinicians at Phoenix Children’s Center for Cancer and Blood Disorders for a year. Because the positions are philanthropically funded by CCN, there is no co-pay for the families, thereby eliminating a significant barrier that has derailed access to counseling for many.

This continues a vital collaboration that began seven years ago.

“In late 2015, Children’s Cancer Network was hearing from childhood cancer families that mental health resources for childhood cancer families were difficult to come by,” relates Patti Luttrell, co-founder and executive director of CCN, noting it was a national issue where counseling took almost three months to get an initial appointment for counseling for childhood cancer patients regardless of where in the country they were located.

“As we researched the issue, CCN wanted to be part of the solution,” she says. So CCN sat down at the table at Phoenix Children’s, where 75% of Arizona’s childhood cancer patients are treated. At the time, she notes, there were no childhood cancer mental health specialists at Phoenix Children’s dedicated to the Center for Cancer and Blood Disorders. The meeting resulted, in early 2016, in an agreement between the two organizations whereby CCN would fund the first part-time family mental health position for the Center for Cancer and Blood Disorders at the hospital.

According to Luttrell, a growing need was quickly noted and, within the next two years, the second part-time mental health clinician was hired and paid for by CCN.

In addition, Phoenix Children’s provides for several mental health therapists embedded in various clinics based on the model in the Center for Cancer and Blood Disorders. —Mike Hunter childrenscancernetwork.org phoenixchildrensfoundation.org